Acer Therapeutics EV - Enterprise Value 2011-2026 | ACER

Annual EV - Enterprise Value Acer Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
38.2 M	57.8 M	41.2 M	30.1 M	171 M	57.8 M	6.06 M	3.76 M	16.9 M	8.55 M	8.37 M	19.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
171 M	3.76 M	38.3 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Burford Capital Limited BUR	3.22 B	$ 4.74	0.53 %	$ 761 M	Britain
Cabaletta Bio CABA	253 M	$ 3.33	2.15 %	$ 335 M	USA
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.07	0.49 %	$ 5.05 M	Israel
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Alnylam Pharmaceuticals ALNY	43.3 B	$ 332.58	-2.01 %	$ 43.6 B	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.8	4.97 %	$ 9.14 B	Australia
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	82.6 M	$ 7.51	-14.07 %	$ 74.2 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Esperion Therapeutics ESPR	1.16 B	$ 2.11	2.77 %	$ 439 M	USA
Evogene Ltd. EVGN	-4.88 M	$ 0.82	-	$ 27.9 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Forte Biosciences FBRX	280 M	$ 32.35	-0.2 %	$ 419 M	USA
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Galapagos NV GLPG	82.8 M	$ 28.99	0.36 %	$ 2.69 B	Belgium
Amphastar Pharmaceuticals AMPH	1.92 B	$ 21.36	-0.09 %	$ 998 M	USA
Genmab A/S GMAB	27 B	$ 29.02	-0.14 %	$ 18.6 B	Danmark
GT Biopharma GTBP	-2.9 M	$ 0.38	-3.34 %	$ 2.1 M	USA
BioNTech SE BNTX	-4.91 B	$ 99.43	1.03 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Hoth Therapeutics HOTH	6.39 M	$ 0.68	4.58 %	$ 9.39 M	USA
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
Harmony Biosciences Holdings HRMY	1.26 B	$ 29.37	0.27 %	$ 1.69 B	USA
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
ImmuCell Corporation ICCC	69.7 M	$ 7.61	-1.55 %	$ 68.7 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	493 M	$ 1.54	-1.28 %	$ 396 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	540 M	$ 4.18	0.6 %	$ 447 M	USA
Arcutis Biotherapeutics ARQT	3.64 B	$ 24.39	-2.79 %	$ 3.1 B	USA
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
Immatics N.V. IMTX	503 M	$ 10.9	-0.46 %	$ 686 M	Germany
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Incyte Corporation INCY	18.2 B	$ 97.43	-0.27 %	$ 19 B	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	629 M	$ 1.46	-1.49 %	$ 389 M	Britain
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Innate Pharma S.A. IPHA	259 M	$ 1.71	4.91 %	$ 235 M	France